Subscribe

Hong Li, PhD

Dr Li is Group Director, Asia Pacific, Global Health Economics and Outcomes Research, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT.

Authored Items
Use Pattern and Off-Label Use of Atypical Antipsychotics in Bipolar Disorder, 1998-2002
Jeffery A. Demland, MS, Renee Rizzo Fleming, RPh, MBA, Yonghua Jing, BPharm, PhD, Christina M. L. Kelton, PhD, Jeff Jianfei Guo, BPharm, PhD, Hong Li, PhD, Patricia R. Wigle, PharmD
June/July 2009, Vol 2, No 4 in Clinical
Prevalence of Treated Bipolar Disorders and Associated Comorbidities in Managed Care and Medicaid Populations
Jeff Jianfei Guo, BPharm, PhD, Nirav R. Shah, MD,MPH, Nick C. Patel, PharmD, PhD, Hong Li, PhD, Paul E. Keck Jr., MD
May/June 2010, Vol 3, No 3 in Clinical
Last modified: September 6, 2013
Copyright © Engage Healthcare Communications, LLC. All rights reserved.